Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

NCT01820962 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

212

Enrollment

OTHER

Sponsor class

Stopped Because the inclusion rate was lower than expected.

Conditions

Hematological Malignancies
Bacteremia
Thrombosis

Interventions

PROCEDURE: heparin
PROCEDURE: concentrated citrate

Sponsor

Maastricht University Medical Center

Collaborators

[object Object]